CSE: TRUE OTC: TREIF 939: FRA
CSE: TRUE OTC: TREIF 939: FRA

Treatment.com AI and Novus Health Partnership Expands Access to its Global Library of Medicine (GLM)

VANCOUVER, British Columbia, May 15, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with Health Care Services International Inc (o/a Novus Health). (“Novus Health”) to explore utilization of Treatment’s proprietary Global Library of Medicine (“GLM”) to further enhance Novus Health’s Health […]

Medical School Renews Contract with Tech Co.

This move further validates the firm’s Medical Education Suite. Discover why one analyst rates this healthcare-disrupting company as a Strong Buy. A leading U.S. medical school renewed its contract to use Treatment.com AI Inc.’s (TRUE:CSE; TREIF:OTCMKTS;939:FRA) Medical Education Suite (MES), the company announced in a news release. MES provides case-based clinical decision-making, testing, grading, and remedial action support to […]

Treatment.com AI Announces Contract Renewal with Leading US Medical School

VANCOUVER, British Columbia, May 1st, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce one of the leading US medical schools has agreed to a contract renewal utilizing Treatment’s Medical Education Suite (“MES”). Treatment is also in discussions with a number of other medical and […]

Treatment.com AI announces new additions to its Medical Education Suite (MES)

VANCOUVER, British Columbia, April 17, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor in a Pocket, to augment its Medical Education Suite (“MES”) designed to educate the next generation of healthcare providers. Treatment’s MES […]